Analysis of laboratory and instrumental data of patients in diabetes mellitus with distal neuropathy and diabetic foot syndrome
Aspirantskiy Vestnik Povolzhiya · 25.05.2026 · 26 (2) · 81-88
DOI: 10.35693/avp690385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aspirantskiy Vestnik Povolzhiya, online erschienen am 25.05.2026. Verfasst von Anna S. Denisyukova und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus, Diabetisches Fußsyndrom
Abstract (Originalsprache)
Aim: to analyze laboratory and instrumental data in patients with type 1 and type 2 diabetes who have sensorimotor DN and neuropathic form of diabetic foot syndrome. Material and methods. The study group included 150 people aged 18 to 70 years, men and women with type 1 and type 2 diabetes, with sensorimotor DN and neuropathic form of diabetic foot syndrome, and 20 healthy people. Research methods: 1) clinical objective research (questionnaire, case history analysis, height and weight measurement with BMI calculation, blood pressure measurement, evaluation of skin condition and condition of nerves of the lower limbs); 2) laboratory tests (glucose, creatinine levels, LDLs, HDLs, triglycerides, total and active B12 level, glycolyzed hemoglobin in total blood, total urine test (albuminuria)) and instrumental tests (electromyography).
Results
One year later, the subjects recorded a decrease in HbA1c by 1% in the group with type 1 and type 2 diabetes with sensorimotor DN (from 9.0% to 8.0%) (p 0.001), and by 1.5% in the group with type 1 and type 2 diabetes, having the sensorimotor and neuropathic form of diabetic foot syndrome with trophic ulcer (from 9.0% to 7.5%) (p 0.001). There was also a decrease in BMI by 0.5–1.0 kg/m2 (p 0.001), a decrease in LDL by 0.5–0.6 mmol/l, and an increase in HDL by 0.1 mmol/l, especially in the group with type 1 and type 2 diabetes, with sensorimotor DN and neuropathic form of diabetic foot syndrome with trophic ulcer, where 73% received statins. A significant decrease in neurological symptoms was observed in patients with type 1 and type 2 diabetes with sensorimotor DN (by 51% on the TSS scale (p=0.00005), by 46% on the NIS-LL scale (p=0.00003) and in patients with type 1 and type 2 diabetes with sensorimotor DN and the neuropathic form of diabetic foot syndrome with trophic ulcer (TSS increased by 68% (p=0.00007), on the NIS-LL scale by 45% (p=0.00004)).
Conclusion
Glycemic control, lipid-lowering and antihypertensive drugs, and timely treatment led to improved metabolic, neurological, and anthropometric parameters and faster healing of leg ulcers in patients with type 1 and type 2 diabetes.
Zitieren
APA
Denisyukova, A. S., & Ivanova, L. A. (2026). Analysis of laboratory and instrumental data of patients in diabetes mellitus with distal neuropathy and diabetic foot syndrome. Aspirantskiy Vestnik Povolzhiya, 26(2), 81-88. https://doi.org/10.35693/avp690385
Vancouver
Denisyukova AS, Ivanova LA. Analysis of laboratory and instrumental data of patients in diabetes mellitus with distal neuropathy and diabetic foot syndrome. Aspirantskiy Vestnik Povolzhiya. 2026;26(2):81-88. doi:10.35693/avp690385
BibTeX
@article{Denisyukova2026,
author = {Denisyukova, Anna S. and Ivanova, Lyudmila A.},
title = {Analysis of laboratory and instrumental data of patients in diabetes mellitus with distal neuropathy and diabetic foot syndrome},
journal = {Aspirantskiy Vestnik Povolzhiya},
year = {2026},
volume = {26},
number = {2},
pages = {81--88},
doi = {10.35693/avp690385}
}
EUVIMED